Impact of Swaddle Blanket on Gastroesophageal Reflux
1 other identifier
interventional
50
1 country
1
Brief Summary
Gastroesophageal reflux disease (GERD) has been reported in up to 85% of all infants born prematurely, and has been associated with a wide range of symptoms. These include irritability, pauses in breathing, heart rate drops, declines in oxygen levels, chronic lung disease, and delays in growth and development. A novel approach to the mangement of GERD in infants is the use of an abdominal band, applying gentle pressure and possibly reducing the reflux of acid from the stomach. The purpose of this study is to evaluate the impact of a swaddle blanket with an abdominal band insert on the incidence of infant apnea, bradycardia, oxygen declines, and pH (acid) changes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2014
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2014
CompletedFirst Submitted
Initial submission to the registry
March 4, 2014
CompletedFirst Posted
Study publicly available on registry
March 11, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedJanuary 21, 2015
January 1, 2015
1.8 years
March 4, 2014
January 19, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
pH
all epochs of pH values below 4.0 will be measured
24 hours
Secondary Outcomes (1)
apnea
24 hours
Other Outcomes (2)
bradycardia
24 hours
oxygen desaturations
24 hours
Study Arms (1)
swaddle blanket
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- \- NICU patients who have a 5 channel study requested by the attending neonatologist -
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Valley Hospital
Ridgewood, New Jersey, 07450, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mary T Carbone, MD
The Valley Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 4, 2014
First Posted
March 11, 2014
Study Start
February 1, 2014
Primary Completion
December 1, 2015
Study Completion
December 1, 2015
Last Updated
January 21, 2015
Record last verified: 2015-01